Published in Proc Natl Acad Sci U S A on May 15, 1992
Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame. RNA (2001) 2.17
Antigenic structure of the complete nonstructural (NS) 2 and 5 proteins of hepatitis C virus (HCV): anti-HCV NS2 and NS5 antibody reactivities in relation to HCV serotype, presence of HCV RNA, and acute HCV infection. Clin Diagn Lab Immunol (1994) 1.00
Molecular basis for antibody cross-reactivity between the hepatitis C virus core protein and the host-derived GOR protein. Clin Exp Immunol (1994) 0.98
Molecular characterization of a structural epitope that is largely conserved among severe isolates of a plant virus. Proc Natl Acad Sci U S A (1993) 0.89
Preliminary study of a dot immunogold filtration assay for rapid detection of anti-HCV IgG. World J Gastroenterol (1999) 0.82
Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science (1989) 37.89
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science (1989) 18.79
Detection of hepatitis C viral sequences in non-A, non-B hepatitis. Lancet (1990) 8.56
The 5'-terminal sequence of the hepatitis C virus genome. Jpn J Exp Med (1990) 5.46
Infectivity of blood seropositive for hepatitis C virus antibodies. Lancet (1990) 4.99
A cDNA fragment of hepatitis C virus isolated from an implicated donor of post-transfusion non-A, non-B hepatitis in Japan. Nucleic Acids Res (1989) 4.29
Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. Br Med Bull (1990) 4.16
Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity. Lancet (1990) 4.01
Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet (1991) 3.97
Recombinant immunoblot assay for hepatitis C virus antibody as predictor of infectivity. Lancet (1990) 2.06
Improved serodiagnosis of hepatitis C virus infection with synthetic peptide antigen from capsid protein. Proc Natl Acad Sci U S A (1991) 1.81
Antibodies against synthetic oligopeptides deduced from the putative core gene for the diagnosis of hepatitis virus infection. Hepatology (1992) 1.81
Detection, semiquantitation, and genetic variation in hepatitis C virus sequences amplified from the plasma of blood donors with elevated alanine aminotransferase. J Clin Invest (1990) 1.70
Enzyme-linked immunosorbent assay for antibodies against the capsid protein of hepatitis C virus with a synthetic oligopeptide. Jpn J Exp Med (1990) 1.13
Tests help nail down HCV--but not entirely. JAMA (1991) 0.85
Experience with a transfusion recipient education program about hepatitis C. Transfusion (1990) 0.80
Complete nucleotide sequence of wild-type hepatitis A virus: comparison with different strains of hepatitis A virus and other picornaviruses. J Virol (1987) 4.49
Distinctive nucleotide sequences adjacent to multiple initiation and termination sites of an early vaccinia virus gene. Cell (1981) 4.42
Transfusion-associated hepatitis not due to viral hepatitis type A or B. N Engl J Med (1975) 3.31
Direct mapping of adeno-associated virus capsid proteins B and C: a possible ACG initiation codon. Proc Natl Acad Sci U S A (1985) 3.31
Australia antigen: large-scale purification from human serum and biochemical studies of its proteins. J Virol (1971) 3.28
Assessment of signs of influenza illness in the ferret model. J Virol Methods (1989) 3.07
Microtiter solid-phase radioimmunoassay for hepatitis B antigen. Appl Microbiol (1973) 2.96
HLA class II antibodies in transfusion-related acute lung injury. Transfusion (2001) 2.93
Molecular cloning and characterization of hepatitis A virus cDNA. Proc Natl Acad Sci U S A (1983) 2.92
Transmissible agent in non-A, non-B hepatitis. Lancet (1978) 2.78
Incompletely base-paired flip-flop terminal loops link the two DNA strands of the vaccinia virus genome into one uninterrupted polynucleotide chain. Cell (1982) 2.76
Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure. N Engl J Med (1976) 2.67
Purification and characterization of a DNA-dependent RNA polymerase from vaccinia virions. J Biol Chem (1980) 2.66
The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease. N Engl J Med (1989) 2.58
A complement-fixation test for measuring Australia antigen and antibody. J Infect Dis (1969) 2.58
SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo. Proc Natl Acad Sci U S A (2001) 2.49
Biophysical properties of Australia antigen. J Virol (1969) 2.45
Clinical and serological analysis of transfusion-associated hepatitis. Lancet (1975) 2.41
Characterization of soluble hepatitis C virus RNA-dependent RNA polymerase expressed in Escherichia coli. J Virol (1999) 2.37
Type B hepatitis after needle-stick exposure: prevention with hepatitis B immune globulin. Final report of the Veterans Administration Cooperative Study. Ann Intern Med (1978) 2.29
Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med (1986) 2.27
Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma. Leukemia (2009) 2.25
Effects of antibody to rotavirus on protection of adults challenged with a human rotavirus. J Infect Dis (1989) 2.21
An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease. Gastroenterology (1999) 2.16
Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E Virus Antibody Serum Panel Evaluation Group. Hepatology (1998) 2.06
Transfusion-associated graft-versus-host disease. Vox Sang (2008) 2.05
A comparison of the frequency of hepatitis-B antigen and antibody in hospital and nonhospital personnel. N Engl J Med (1973) 2.05
Radioimmunoassay for the detection of the core of the Dane particle and antibody to it. Intervirology (1974) 2.02
Seroepidemiology of viral infections among intravenous drug users in northern California. West J Med (1992) 2.01
Questionable efficacy of confidential unit exclusion. Transfusion (1990) 1.81
Prevalence of and risk factors for antibody to hepatitis E virus seroreactivity among blood donors in Northern California. J Infect Dis (1997) 1.79
Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission. J Virol (1995) 1.77
Biophysical characterization of the adr subtype of hepatitis B antigen and preparation of anti-r sera in rabbits. J Immunol (1975) 1.75
Human rotavirus studies in volunteers: determination of infectious dose and serological response to infection. J Infect Dis (1986) 1.68
Orientation of prophage Mu. Virology (1973) 1.67
Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors. Ann Intern Med (1972) 1.64
Improved survival with plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Am J Med (1999) 1.63
Preparation and characterization of complement-fixing hepatitis-associated antigen and antiserum. J Infect Dis (1970) 1.62
Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients: frequent long-term microchimerism in severe trauma patients. Blood (1999) 1.59
Subtyping of hepatitis-associated antigen (HB-Ag); simplified technique with counterelectrophoresis. J Immunol (1972) 1.54
Thalidomide and its analogues inhibit lipopolysaccharide-mediated Iinduction of cyclooxygenase-2. Clin Cancer Res (2001) 1.53
Encephalitis associated with erythema infectiosum. J Pediatr (1970) 1.51
Cell-mediated immunity in humans during viral infection. I. Effect of rubella on dermal hypersensitivity, phytohemagglutinin response, and T lymphocyte numbers. Infect Immun (1974) 1.50
Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus. J Virol (1988) 1.49
An open-label, single-arm pilot study in patients with severe plaque-type psoriasis treated with an oral anti-inflammatory agent, apremilast. Curr Med Res Opin (2008) 1.49
Cationic lipid enhances in vitro receptor-mediated transfection. Am J Med Sci (1994) 1.47
Hepatitis C virus internal ribosome entry site (IRES) stem loop IIId contains a phylogenetically conserved GGG triplet essential for translation and IRES folding. J Virol (2000) 1.47
Lyme disease--another transfusion risk? Transfusion (1989) 1.45
Hepatitis C virus is detected in a monocyte/macrophage subpopulation of peripheral blood mononuclear cells of infected patients. J Infect Dis (1992) 1.45
Counterelectrophoresis for detection of hepatitis--associated antigen: methodology and comparison with gel diffusion and complement fixation. J Lab Clin Med (1971) 1.44
Tight clustering of human hepatitis B virus integration sites in hepatomas near a triple-stranded region. J Virol (1987) 1.42
Replacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects. J Clin Invest (1981) 1.41
The metabolism of the lungs from normal mice and from mice exposed to phosgene. Biochem J (1948) 1.39
Transmission of rubella from newborns. A controlled study among young adult women and report of an unusual case. Am J Dis Child (1965) 1.39
HIV transmissions from a window-period platelet donation. Am J Clin Pathol (2001) 1.38
Non-A, non-B hepatitis and antibody to hepatitis C virus. JAMA (1990) 1.37
Structure and replication of vaccinia virus telomeres. Cold Spring Harb Symp Quant Biol (1983) 1.36
A human monoclonal antibody that recognizes viral polypeptides and in vitro translation products of the genome of the hepatitis D virus. J Infect Dis (1987) 1.32
Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants. J Infect Dis (1990) 1.32
Circannual variation in lymphocyte subsets, revisited. Transfusion (1994) 1.32
Sequence analysis of hepatitis A virus cDNA coding for capsid proteins and RNA polymerase. Proc Natl Acad Sci U S A (1985) 1.32
An ultraviolet-sensitive RNA structural element in a viroid-like domain of the hepatitis delta virus. Science (1989) 1.31
Mouse c-mos oncogene activation is prevented by upstream sequences. Proc Natl Acad Sci U S A (1984) 1.30
Detection of a genome-linked protein (VPg) of hepatitis A virus and its comparison with other picornaviral VPgs. J Virol (1986) 1.29
Effect of viral and bacterial pneumonias on cell-mediated immunity in humans. Infect Immun (1976) 1.29
Reye's syndrome: epidemiologic and viral studies, 1963-1974. Am J Epidemiol (1975) 1.28
A study of erythema infectiosum: recovery of rubella virus and echovirus-12. Pediatrics (1972) 1.27
Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test. Transfusion (2005) 1.26
False positive tests for hepatitis-associated antigen in blood donors caused by antibodies to ruminant serum proteins. J Immunol (1972) 1.26
Hepatitis delta virus (HDV) and woodchuck hepatitis virus (WHV) nucleic acids in tissues of HDV-infected chronic WHV carrier woodchucks. J Virol (1989) 1.26
Donor transaminase and recipient hepatitis. Impact on blood transfusion services. JAMA (1981) 1.24
Ranitidine: a new H2-receptor antagonist. N Engl J Med (1983) 1.24
Relation of hepatitis-B-antigen subtypes in symptom-free carriers to geographical origin and liver abnormalities. Lancet (1973) 1.23
Protection from rotavirus reinfection: 2-year prospective study. J Infect Dis (1991) 1.23
Transmission of hepatitis B to chimpanzees by hepatitis B surface antigen-positive saliva and semen. Infect Immun (1977) 1.22
A seroepidemiologic study of a measles epidemic in a highly immunized population. Am J Epidemiol (1972) 1.21
The Duffy blood group phenotype in American blacks infected with Plasmodium vivax in Vietnam. Am J Trop Med Hyg (1978) 1.21
Evidence for natural reassortants of human rotaviruses belonging to different genogroups. J Virol (1990) 1.20
Generation of transmissible hepatitis C virions from a molecular clone in chimpanzees. Virology (1999) 1.18
Evidence for replication of hepatitis delta virus RNA in hepatocyte nuclei after in vivo infection. Virology (1988) 1.17
Association of Reye's syndrome with viral infection. Lancet (1974) 1.17
The development of HBsAg-positive hepatitis despite the previous existence of antibody to HBsAg. J Immunol (1976) 1.16
Irradiation of blood products. Indications and guidelines. Transfusion (1985) 1.16
Health-care workers positive for hepatitis B surface antigen. Are their contacts at risk? N Engl J Med (1975) 1.15
Primary hepatocellular carcinoma in idiopathic hemochromatosis after reversal of cirrhosis. Gastroenterology (1988) 1.13
The Ausria test: critical evaluation of sensitivity and specificity. Blood (1973) 1.13
Cellular immune response to cytomegalovirus infection after renal transplantation. Infect Immun (1978) 1.13
Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12. Vaccine (1998) 1.12
Growth of bacteria in inoculated platelets: implications for bacteria detection and the extension of platelet storage. Transfusion (2000) 1.12
Differentiation of hepatitis B virus genotypes D and E by ELISA using monoclonal antibodies to epitopes on the preS2-region product. J Virol Methods (2000) 1.12
Anti-HIV seroprevalence in California blood and plasma donors. West J Med (1988) 1.12
Complement is activated in the upper respiratory tract during influenza virus infection. Am Rev Respir Dis (1991) 1.11
In vitro hepatitis B virus infection of human bone marrow cells. J Clin Invest (1986) 1.11
Rubella-vaccinated students. Follow-up in a public school system. JAMA (1978) 1.10
Measles IgM response during reinfection of previously vaccinated children. J Pediatr (1973) 1.10
Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3. J Virol (2000) 1.10
Rubella vaccine evaluation in a public school system. Am J Dis Child (1969) 1.09
Hepatitis B antigen: regional variation in incidence and subtype ratio in the American Red Cross donor population. Am J Epidemiol (1973) 1.08